顺式-2-[(1,3-二氢-1,3-二氧-2H-异吲哚-2-基)甲基-N,N-二乙基-1-苯基环丙烷甲酰胺结构式
|
常用名 | 顺式-2-[(1,3-二氢-1,3-二氧-2H-异吲哚-2-基)甲基-N,N-二乙基-1-苯基环丙烷甲酰胺 | 英文名 | cis-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-N,N-diethyl-1-phenylcyclopropanecarboxamide |
|---|---|---|---|---|
| CAS号 | 105310-75-6 | 分子量 | 376.448 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 546.1±29.0 °C at 760 mmHg | |
| 分子式 | C23H24N2O3 | 熔点 | 130-132ºC | |
| MSDS | N/A | 闪点 | 237.5±16.6 °C |
| 中文名 | 顺式-2-[(1,3-二氢-1,3-二氧-2H-异吲哚-2-基)甲基-N,N-二乙基-1-苯基环丙烷甲酰胺 |
|---|---|
| 英文名 | cis-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-N,N-diethyl-1-phenylcyclopropanecarboxamide |
| 中文别名 | 顺式-2-[(1,3-二氢-1,3-二氧异吲哚-2-)甲基-N,N-二乙基-1-苯基环丙烷酰胺 |
| 英文别名 | 更多 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 546.1±29.0 °C at 760 mmHg |
| 熔点 | 130-132ºC |
| 分子式 | C23H24N2O3 |
| 分子量 | 376.448 |
| 闪点 | 237.5±16.6 °C |
| 精确质量 | 376.178680 |
| PSA | 57.69000 |
| LogP | 3.45 |
| InChIKey | JOTWZGIFEGRKFM-HXOBKFHXSA-N |
| SMILES | CCN(CC)C(=O)C1(c2ccccc2)CC1CN1C(=O)c2ccccc2C1=O |
| 蒸汽压 | 0.0±1.5 mmHg at 25°C |
| 折射率 | 1.620 |
| 海关编码 | 2925190090 |
|---|
|
~%
顺式-2-[(1,3-二氢-1... 105310-75-6 |
| 文献:Journal of Medicinal Chemistry, , vol. 30, # 2 p. 318 - 325 |
|
~%
顺式-2-[(1,3-二氢-1... 105310-75-6 |
| 文献:WO2011/158249 A1, ; |
|
~%
顺式-2-[(1,3-二氢-1... 105310-75-6 |
| 文献:Journal of Medicinal Chemistry, , vol. 30, # 2 p. 318 - 325 |
|
~%
顺式-2-[(1,3-二氢-1... 105310-75-6 |
| 文献:Journal of Medicinal Chemistry, , vol. 30, # 2 p. 318 - 325 |
| 海关编码 | 2925190090 |
|---|---|
| 中文概述 | 2925190090 其他酰亚胺及其衍生物盐. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
| (1R,2S)-2-[(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropanecarboxamide |
| 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)Methyl-N,N-diethyl-1-phenylcyclopropanecarboxaMide,cis |
| (1R,2S)-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropanecarboxamide |
| 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-N,N-diethyl-1-phenylcyclopropa |
| (1R,2S)-N,N-diethyl-2-[(1,3-dioxoisoindolin-2-yl)methyl]-1-phenylcyclopropanecarboxamide |
| 1-phenyl-1-diethylaminocarbonyl-2-phthaIimidomethylcyclopropane |
| (1R,2)-2-[(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenyl-cyclopropanecarboxamide |
| (Z)-1-phenyl-2-(phthalimidomethyl)N,N-diethylcyclopropanecarboxamide |
| (Z)-1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethylcyclopropane |
| cis-(+/-)-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenyl cyclopropanecarboxamide |
| (1SR,2RS)-2-((1,3-dioxoisoindolin-2-yl)methyl)-N,N-diethyl-1-phenylcyclopropane carboxamide |
| Cyclopropanecarboxamide, 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenyl-, (1R,2S)- |
| (1R,2S)-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl] |